{"schema_version":"secwatch.filing_event.v1","accession":"0000927066-22-000075","form_type":"8-K","ticker":"DVA","cik":"0000927066","company_name":"DAVITA INC.","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.454678+00:00","generated_at":"2026-06-26T00:15:56.941123+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"DaVita Q1 2022 EPS $1.61, down 10% from prior quarter; revenue $2.818B","bullets":["Diluted EPS of $1.61 vs $1.79 in Q4 2021 and $2.09 in Q1 2021; adjusted EPS $1.61.","Consolidated revenue of $2.818 billion for the quarter.","Operating income of $338 million; operating cash flow $322 million, free cash flow $147 million.","Repurchased 2.1 million shares at avg cost $110.90 per share.","COVID-19 Omicron variant caused higher patient mortality and missed treatments, plus wage inflation."],"urls":{"canonical":"https://secwatch.observer/filing/0000927066-22-000075","json":"https://secwatch.observer/filing/0000927066-22-000075.json","markdown":"https://secwatch.observer/filing/0000927066-22-000075.md","text":"https://secwatch.observer/filing/0000927066-22-000075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927066/000092706622000075/0000927066-22-000075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927066/000092706622000075/dva-20220505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:15:56.941123+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}